TiO_2在MCM-41内表面单层及双层分散的结构表征

首次以有机物钛酸丁酯为前驱体,合成了ＴｉＯ２呈单层分散状态（Ｔｉ／Ｓｉ＝０.２０）或双层分散状态（Ｔｉ／Ｓｉ＝０．３９）的介孔分子筛ＭＣＭ－４１（Ｓｉ／Ａｌ＝３５）,并以 ＸＲＤ,ＦＴＩＲ,Ｎ２吸附－脱附,固体ＵＶ－ｖｉｓ 漫反射等表征手段对其结构特征和氧化钛分散状态进行了研究．结果表明： ＴｉＯ２在介孔分子筛ＭＣＭ－４１孔道中分散, ＭＣＭ－４１骨架结构结晶度降低,但是附着二层ＴｉＯ２后,仍能保持长程有序结构; ＴｉＯ２与ＭＣＭ－４１孔道表面的ＳｉＯ２以化学键连接,生成Ｓｉ－Ｏ—Ｔｉ键;无论是单层还是双层分散的 ＴｉＯ２在 ＭＣＭ－４１内孔壁均匀分散;且由于ＴｉＯ２粒子的减小使其对紫外光的吸收发生明显的蓝移现象．     

温和条件下介孔分子筛MCM-41的修饰与表征

在温和条件下,以３－氨丙基三乙氧基硅烷为偶联剂,修饰介孔分子筛 ＭＣＭ－４１（Ｓｉ／Ａｌ＝３５）,成功地将有机官能团引入到介孔分子筛孔道中,制备了一种无机一有机复合材料ＭＣＭ－（ＣＨ_２）_３ＮＨ_２,以 ＸＲＤ、ＦＴＩＲ、ＤＴＡ－ＴＧＡ、 Ｎ_２吸附－脱附和 ＨＲＥＭ表征了复合材料;结果表明：有机基团－（ＣＨ_２）_３ＮＨ_２不仅进人孔道、修饰了ＭＣＭ－４１的孔壁,而且使介孔分子筛ＭＣＭ－４１保持了有序的孔道结构．     

纳米Au团簇在氧化钛修饰的介孔分子筛MCM-41中的组装

以钛酸丁酯为ＴｉＯ_２前驱体,使ＴｉＯ_２均匀分散于纯硅介孔分子筛ＭＣＭ－４１的介孔孔道内表面,利用ＴｉＯ_２光学性质将ＡｕＣｌ－４还原为Ａｕ（０）并组装于氧化钛修饰的ＭＣＭ－４１孔道中．对所合成的Ａｕ负载的氧化钛修饰的ＭＣＭ－４１进行了ＸＲＤ,ＸＰＳ,Ｎ_２吸附－脱附曲线,及固体ＵＶ－Ｖｉｓ漫反射等多种结构表征．由ＸＰＳ谱和固体ＵＶ－Ｖｉｓ漫反射吸收光谱的ｐｌａｓｍｏｎ吸收峰证明Ａｕ团簇呈现０价的金属状态．     

Ti(IV)在介孔氧化硅MCM-41中的液相移植

以钛酸丁酯为原料,通过液相移植反应,在介孔氧化硅ＭＣＭ－４１中成功地组装了Ｔｉ（ＩＶ）,利用ＸＲＤ、ＴＥＭ、ＥＤＳ、ＦＴ－ＩＲ、Ｎ_２吸附－脱附、^２９Ｓｉ ＭＡＳ ＮＭＲ等多种实验方法对材料进行了表征,并讨论了液相移植反应的机理．实验表明,通过与介孔材料骨架表面Ｑ^３硅原子中的硅醇键（Ｓｉ－ＯＨ）的反应而形成钛－氧－硅（Ｔｉ－Ｏ－Ｓｉ）键,Ｔｉ（ＩＶ）被成功地固定到介孔材料的骨架上面; ９５０～９６０ｃｍ^－１红外共振吸收的加强是Ｓｉ－Ｏ－Ｔｉ键形成的标志．     

六方棱柱结构介孔氧化硅材料的合成及其机制探讨

在强酸性条件下合成了具有六方棱柱结构的介孔氧化硅ＭＣＭ－４１材料,并通过ＸＲＤ、氮气吸附、ＳＥＭ、ＨＲＴＥＭ等手段对材料性能进行了表征。结果表明：在微米尺度上具有六棱柱结构的ＭＣＭ－４１材料,是由定向规则排列的纳米孔道组成,表面附着硅酸根离子的表面活性剂胶束按照液晶几何构造定向聚集生长,是导致六方棱柱结构介孔材料形貌生成的主要原因。     

金属Pt团簇在氧化钛修饰MCM-41中的组装

采用光沉积的合成方法将纳米金属Ｐｔ组装于氧化钛修饰ＭＣＭ－４１孔道中,并对合成的样品进行了ＸＲＤ、ＸＰＳ、ＵＶ－vis、Ｎ₂吸附－脱附等结构表征．光电子能谱表明组装的Ｐｔ呈金属状态;Ｎ_２吸附－脱附数据表明组装于孔道中的Ｐｔ虽然使ＭＣＭ－４１的ＢＥＴ比表面和孔容下降,但是由于Ｐｔ的组装量较小,使其对孔径分布的影响较小．由于Ｐｔ的引入,使其紫外－可见光漫反射吸收光谱与氧化钛修饰的ＭＣＭ－４１不同．     

钛掺杂对介孔硅材料结构性能的影响

在室温碱性条件下合成了Ｔｉ掺杂的介孔硅材料ＭＣＭ－４１,借助ＸＲＤ,ＩＲ、ＨＲＥＭ和Ｎ２吸附等分析手段,探讨了Ｔｉ掺杂量对介孔材料结构和性能的影响。结果表明：掺杂的Ｔｉ离子可以进行Ｓｉ骨架,并生成Ｓｉ－Ｏ－Ｔｉ键。     

医用NiTi合金表面溶胶-凝胶法制备TiO2-SiO2薄膜

采用溶胶－凝胶法在ＮiTi形状记忆合金表面制备了ＴiO2-SiO2复合薄膜,在提高医用ＮiTi合金的抗腐蚀性方面,收到了显著的效果,运用电化学方法对不同组成的ＴiO2-SiO2薄膜的抗腐蚀性增强,划痕试验一ＴiO2-SiO2(Ti/Si=4:1)膜与ＮiTi合金基体具有较高的界面结合强度,用原子力显微镜（ＡＦＭ）对ＴiO2-SiO2薄膜的表面形貌及表面粗糙度进行观察和分析,解释并讨论了TiO2-SiO2薄膜的配方组成与其抗腐蚀的关系,ＳiO２含量较少时,薄膜结构致密,膜层均匀平滑,且膜基结合力,作为医用ＮiTi合金的表面保护层,可以使其耐腐蚀性有显著提高。     

配合物[Mn(phen)_2]~(2 )修饰的MCM-41的合成与表征

分别以γ－氨丙基和甲基丙烯酸丙酯基修饰介孔分子筛ＭＣＭ－４１内孔壁,将引入的有机官能团与金属配位离子［Ｍｎ（ｐｈｅｎ）２Ｃｌ］＋通过配位健成键首次合成了锰（Ⅱ）配位化合物修饰的ＭＣＭ－４１（ＭＣＭ－ａｐ－Ｍｎ（ｐｈｅｎ）２,ＭＣＭ－ｍｐ－Ｍｎ（Ｐｈｅｎ）２）．通过ＸＲＤ、ＦＴＩＲ、７７Ｋ氮气吸附－脱附、ＵＶ－ＶＩＳ漫反射光谱和Ｍｎ２＋电子顺磁共振谱（ＥＳＲ）表征了复合物ＭＣＭ－ａｐ－Ｍｎ（ｐｈｅｎ）２和ＭＣＭ－ｍｐ－Ｍｎ（ｐｈｅｎ）２由于有机基团对ＭＣＭ－４１孔壁的修饰,使复合物的结晶度降低,增加的有机基因和配合物使红外光谱有所改变;ＢＥＴ比表面积,孔容和最可几孔径均下降;γ－氨丙基或甲基丙烯酸丙酯基与Ｍｎ２＋的配位而使其ＵＶ－ＶＩＳ漫反射吸收光谱在短波长的吸收加强;室温下 Ｍｎ２＋电子顺磁共振表明 Ｍｎ（Ⅱ）配位环境几乎没有变化．     

介孔分子筛/线性酚醛树脂杂化材料的制备及表征

利用水热法合成介孔分子筛(SBA-15),选择KH560对其表面进行修饰后采用原位聚合的方法制备了介孔分子筛/线性酚醛树脂(SBA-15/PF)有机无机杂化材料。通过傅立叶红外光谱(FT-IR)、X射线衍射(XRD)、N2吸附和热失重分析(TGA)等表征手段对杂化材料的制备过程进行跟踪研究。结果表明,KH-560已嫁接到SBA-15的内外表面,线性酚醛树脂分布于介孔分子筛孔道内外,并与SBA-15存在键接作用,形成有机无机互穿网络结构;表面修饰过程对SBA-15有序结构影响较小,而原位聚合会破坏介孔分子筛部分有序结构。     

配合物[Fe(bipy)2]3+修饰的MCM-41的合成与表征

以γ－氨丙基修饰介孔分子筛ＭＣＭ－４１内孔壁,将引入的γ－氨丙基与金属配位离子［Ｆｅ（ｂｉｐｙ）_２］^３＋通过配位键首次合成了金属配位化合物修饰的ＭＣＭ－４１（ＭＣＭ－ａｐ－Ｆｅ（ｂｉｐｙ）_２）．通过ＸＲＤ,７７Ｋ氮气吸附－脱附曲线,固体ＵＶ－ｖｉｓ漫反射光谱和循环伏安曲线表征了复合物ＭＣＭ－ａｐ－Ｆｅ（ｂｉｐｙ）_２。由于［Ｆｅ（ｂｉｐｙ）_２］^３＋的引入,使 ＭＣＭ－ａｐ－Ｆｅ（ｂｉｐｙ）_２的结晶度降低, ＢＥＴ比表面积、孔容和最可几孔径急剧下降．γ－氨丙基与Ｆｅ^３＋的配位而使其ＵＶ－ｖｉｓ漫反射吸收光谱与ＭＣＭ－Ｆｅ（ｂｉｐｙ）_２不同;循环伏安特性曲线表明ＭＣＭ－ａｐ－Ｆｅ（ｂｉｐｙ）_２在电化学上比浸渍法制备的ＭＣＭ－Ｆｅ（ｂｉｐｙ）_２稳定．     

Amine-impregnated MCM-41 in post-combustion CO2 capture: Synthesis,characterization, isotherm modelling

In this study, a composite mesoporous silica material MCM-41 (Mobil composite matter) is impregnated with monoethanolamine (MEA) as primary linear amine, benzylamine (BZA) as primary cyclic amine and N-(2-aminoethyl) ethanolamine (AEEA) as secondary diamine and the effects of amine loading, amine type, CO₂ partial pressure and adsorption temperatures on the CO₂ adsorption are investigated. The CO₂ adsorption performances of MCM-41 and amine impregnated MCM-41 samples are studied up to 1 bar of CO₂ partial pressure and the temperature range of 25–60 °C. The amine loadings (% impregnation) are optimized for maximum CO₂ uptake. The materials are characterised using N₂ adsorption/desorption isotherm, Fourier Transform Infrared (FT-IR) Spectroscopy, Thermogravimetric (TGA) and Elemental (CHNS) analysis. The materials have shown good structural and thermal stability. The MCM-41-40%AEEA, MCM-41-40%BZA and MCM-41-50%MEA samples are exhibited the CO₂ adsorption capacity of 2.34 mmol/g (102.98 mg/g), 0.908 mmol/g (39.96 mg/g) and 1.47 mmol/g (64.69 mg/g) respectively. The CO₂ uptake of MCM-41-40%AEEA is 3.5 times higher than that of in MCM-41 (0.68 mmol/g) and it is also the highest reported value as di-amine impregnated MCM-41. The results indicated that the adsorption capacities of the materials (MCM-41 and MCM-41-40%AEEA) are decreased with an increase of adsorption temperature in the range of 25–60 °C. The Freundlich, Langmuir, Sips and Toth isotherm models are used to correlate and predict experimental CO₂ adsorption data. The Sips and Toth isotherm models are found to be better fitted with the experimental data. The isosteric heat of adsorption of MCM-41 and MCM-41-40%AEEA samples are also calculated from Van’t Hoff plot using iSorbHP-win instrumental analysis software in the experimental temperature range.     

The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol

Objective: To explore the suitable application of MCM-41 (Mobil Composition of Matter number forty-one)-type and MCM-48-type mesoporous silica in the oral water insoluble drug delivery system.

Methods: Cilostazol (CLT) as a model drug was loaded into synthesized MCM-48 (Mobil Composition of Matter number forty-eight) and commercial MCM-41 by three common methods. The obtained MCM-41, MCM-48 and CLT-loaded samples were characterized by means of nitrogen adsorption, thermogravimetric analysis, ultraviolet-visible spectrophotometry, scanning electron microscopy, transmission electron microscopy, differential scanning calorimetry and powder X-ray diffractometer.

Results: It was found that solvent evaporation method was preferred according to the drug loading efficiency and the maximum percent cumulative drug dissolution. MCM-48 with 3D cubic pore structure and MCM-41 with 2D long tubular structure are nearly spherical particles in 300–500?nm. Nevertheless, the silica carriers with similar large specific surface areas and concentrating pore size distributions (978.66?m²/g, 3.8?nm for MCM-41 and 1108.04?m²/g, 3.6?nm for MCM-48) exhibited different adsorption behaviors for CLT. The maximum percent cumulative drug release of the two CLT/silica solid dispersion (CLT-MCM-48 and CLT-MCM-41) was 63.41% and 85.78% within 60?min, respectively; while in the subsequent 12?h release experiment, almost 100% cumulative drug release were both obtained. In the pharmacokinetics aspect, the maximum plasma concentrations of CLT-MCM-48 reached 3.63?mg/L by 0.92?h. The AUC_0–∞ values of the CLT-MCM-41 and CLT-MCM-48 were 1.14-fold and 1.73-fold, respectively, compared with the commercial preparation.

Conclusion: Our findings suggest that MCM-41-type and MCM-48-type mesoporous silica have great promise as solid dispersion carriers for sustained and immediate release separately.     

Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene

In the present work, MCM-41 and MCM-48 type of nanoparticles were successfully engineered. Effect of nanosize and amine functionalization on drug release, in vitro intestinal absorption and in vivo pharmacokinetic behavior was investigated in a comprehensive manner. The tailor-made bare and surface decorated MCM-41 and MCM-48 were synthesized and evaluated for their mesoporous skeleton, pore size, particle size, surface area, zeta potential, etc. by nitrogen sorption, DLS, TEM, etc. Incorporation of raloxifene (RLF) was affirmed using optimized immersion-solvent evaporation technique and its success confirmed by DSC, IR, and XRD analysis. TGA analysis revealed higher %grafting of amine groups on the exterior and larger RLF encapsulation into mesoporous derivate. The detailed in vitro release study revealed SGF to be the most compatible media for RLF showing an initial burst release from pristine nanoparticles and a delayed release from surface coated nanoparticles. Furthermore, release kinetics model data demonstrated Weibull and Higuchi as the best fit models for bare and amine-functionalized nanoparticles respectively. Moreover, an in vitro permeability study on Caco-2 cell line revealed higher absorption by engineered nanoparticle as compared to pure RLF and its marketed formulation. The supremacy in the in vivo pharmacokinetic parameters of RLF-41 and RLF-48 was demonstrated with 3.33 and 3.50 times enhancement in the bioavailability of RLF with respect to RLF suspension. To sum up, the results obtained were superior and promising for synthesized nanoparticles and more precisely for MCM-48 amongst them.     

Functionalization of mesoporous MCM-41 for the delivery of curcumin as an anti-inflammatory therapy

In this study, mesoporous silica nanoparticles (MSNs) composed of MCM-41 were synthesized and modified with amine groups (i.e., NH₂) to form NH_2/MCM-41, which was loaded with curcumin (CUR) to form CUR@NH₂/MCM-41 to create an efficient carriers in drug delivery systems (DDSs). The three samples (i.e., pure MCM-41, NH₂/MCM-41, and CUR@NH₂/MCM-41) were characterized using X-ray diffraction (XRD), Brunauer-Emmett-Teller (BET) surface area, Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), transition electron microscopy (TEM), and a thermogravimetric analyzer (TGA). The study investigated the effect of the carrier dose, CUR concentration, pH, and contact time on the drug loading efficiency (DLE%) by adsorption. The best DLE% for MCM-41 and NH₂/MCM-41 was found to be 15.78 and 80%, respectively. This data demonstrated that the Langmuir isotherm had a greater correlation coefficient (R²) of 0.9840 for MCM-41 and 0.9666 for NH₂/MCM-41 than the Freundlich and Temkin isotherm models. A pseudo-second-order kinetic model seems to fit well with R² = 0.9741 for MCM-41 and R² = 0.9977 for NH₂/MCM-41. A phosphate buffer solution (PBS) with a pH of 7.4 was utilized to study CUR release behavior. As a result, the full release after 72 h was found to have a maximum of 74.1% and 29.95% for pure MCM-41 and NH₂/MCM-41, respectively. The first-order, Weibull, Hixson-Crowell, Korsmeyer-Peppas, and Higuchi kinetic release models were applied to releasing CUR from CUR@MCM-41 and CUR@NH₂/MCM-41. The Weibull kinetic model fit well, with R² = 0.944 and 0.96912 for pure MCM-41 and NH₂/MCM-41, respectively.